The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Christopher H. van Dyck

Azheimer's Disease Research Unit

Department of Psychiatry

Yale University School of Medicine

New Haven



Name/email consistency: high



  • Azheimer's Disease Research Unit, Department of Psychiatry, Yale University School of Medicine, New Haven, USA. 1998 - 2009


  1. Cognitive and psychiatric effects of vitamin B12 replacement in dementia with low serum B12 levels: a nursing home study. van Dyck, C.H., Lyness, J.M., Rohrbaugh, R.M., Siegal, A.P. Int. Psychogeriatr (2009) [Pubmed]
  2. Striatal dopamine transporters correlate with simple reaction time in elderly subjects. van Dyck, C.H., Avery, R.A., MacAvoy, M.G., Marek, K.L., Quinlan, D.M., Baldwin, R.M., Seibyl, J.P., Innis, R.B., Arnsten, A.F. Neurobiol. Aging (2008) [Pubmed]
  3. Imaging microglial activation in Alzheimer's disease: what does it mean?. van Dyck, C.H. Biol. Psychiatry (2008) [Pubmed]
  4. A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease. van Dyck, C.H., Tariot, P.N., Meyers, B., Malca Resnick, E. Alzheimer. Dis. Assoc. Disord (2007) [Pubmed]
  5. A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil. van Dyck, C.H., Schmitt, F.A., Olin, J.T. Am. J. Geriatr. Psychiatry (2006) [Pubmed]
  6. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. van Dyck, C.H., Malison, R.T., Jacobsen, L.K., Seibyl, J.P., Staley, J.K., Laruelle, M., Baldwin, R.M., Innis, R.B., Gelernter, J. J. Nucl. Med. (2005) [Pubmed]
  7. Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype. van Dyck, C.H., Malison, R.T., Staley, J.K., Jacobsen, L.K., Seibyl, J.P., Laruelle, M., Baldwin, R.M., Innis, R.B., Gelernter, J. Am. J. Psychiatry (2004) [Pubmed]
  8. Understanding the latest advances in pharmacologic interventions for Alzheimer's disease. van Dyck, C.H. CNS. Spectr (2004) [Pubmed]
  9. Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. van Dyck, C.H., Seibyl, J.P., Malison, R.T., Laruelle, M., Zoghbi, S.S., Baldwin, R.M., Innis, R.B. Am. J. Geriatr. Psychiatry (2002) [Pubmed]
  10. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. van Dyck, C.H., Quinlan, D.M., Cretella, L.M., Staley, J.K., Malison, R.T., Baldwin, R.M., Seibyl, J.P., Innis, R.B. Am. J. Psychiatry (2002) [Pubmed]
  11. Neuroimaging in Alzheimer's disease: relevance for treatment. van Dyck, C.H. Curr. Psychiatry. Rep (2001) [Pubmed]
  12. Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group. van Dyck, C.H., Newhouse, P., Falk, W.E., Mattes, J.A. Arch. Gen. Psychiatry (2000) [Pubmed]
  13. Age-related decline in central serotonin transporter availability with [(123)I]beta-CIT SPECT. van Dyck, C.H., Malison, R.T., Seibyl, J.P., Laruelle, M., Klumpp, H., Zoghbi, S.S., Baldwin, R.M., Innis, R.B. Neurobiol. Aging (2000) [Pubmed]
  14. Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm. van Dyck, C.H., Soares, J.C., Tan, P.Z., Staley, J.K., Baldwin, R.M., Amici, L.A., Fu, X., Garg, P.K., Seibyl, J.P., Charney, D.S., Innis, R.B. Nucl. Med. Biol. (2000) [Pubmed]
  15. Absence of an apolipoprotein E epsilon4 allele is associated with increased parietal regional cerebral blood flow asymmetry in Alzheimer disease. van Dyck, C.H., Gelernter, J., MacAvoy, M.G., Avery, R.A., Criden, M., Okereke, O., Varma, P., Seibyl, J.P., Hoffer, P.B. Arch. Neurol. (1998) [Pubmed]
WikiGenes - Universities